<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>Bioequivalence Tests for Parallel Trial Designs: 3 Arms, 1 Endpoint</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { display: inline-block; text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">

div.csl-bib-body { }
div.csl-entry {
clear: both;
margin-bottom: 0em;
}
.hanging div.csl-entry {
margin-left:2em;
text-indent:-2em;
}
div.csl-left-margin {
min-width:2em;
float:left;
}
div.csl-right-inline {
margin-left:2em;
padding-left:1em;
}
div.csl-indent {
margin-left: 2em;
}
</style>

<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Bioequivalence Tests for Parallel Trial
Designs: 3 Arms, 1 Endpoint</h1>



<p>In the <code>SimTOST</code> R package, which is specifically designed
for sample size estimation for bioequivalence studies, hypothesis
testing is based on the Two One-Sided Tests (TOST) procedure. <span class="citation">(<a href="#ref-sozu_sample_2015">Sozu et al.
2015</a>)</span> In TOST, the equivalence test is framed as a comparison
between the the null hypothesis of ‘new product is worse by a clinically
relevant quantity’ and the alternative hypothesis of ‘difference between
products is too small to be clinically relevant’. This vignette focuses
on a parallel design, with 3 arms/treatments and 1 primary endpoint.</p>
<div id="introduction" class="section level1">
<h1>Introduction</h1>
<p>This vignette demonstrates advanced sample size calculation
techniques for parallel trial designs involving three arms and one
endpoint. Specifically, we calculate the required sample size to test
bioequivalence between a new treatment (SB2) and a reference product
(Remicade) administered in two different locations (“EU_Remicade” and
“USA_Remicade”). The endpoint of interest is the Area Under the Curve
(AUCinf), a commonly used pharmacokinetic measure.</p>
<p>In this example, we assume the endpoint follows a log-normal
distribution with equal variances across arms. The goal is to determine
the sample size needed to achieve 90% power while controlling the type I
error rate at 5%. The equivalence margin is defined as <span class="math inline">\(E_L = 80\%\)</span> and <span class="math inline">\(E_U = 125\%\)</span> of the reference mean on the
original scale.</p>
<p>The methods presented in this vignette build on fundamental
bioequivalence testing concepts and extend them to multi-arm scenarios.
These examples provide practical insights for designing robust parallel
trials with complex equivalence testing requirements.</p>
<p>We assume that the primary endpoint, AUCinf, is on the original
scale, with the mean and standard deviation for each arm available. This
information is organized into a structured data table for further
analysis:</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a><span class="fu">library</span>(SimTOST)</span>
<span id="cb1-2"><a href="#cb1-2" tabindex="-1"></a></span>
<span id="cb1-3"><a href="#cb1-3" tabindex="-1"></a>data <span class="ot">&lt;-</span> data.table<span class="sc">::</span><span class="fu">data.table</span>(<span class="at">arm =</span> <span class="fu">c</span>(<span class="st">&quot;SB2&quot;</span>,<span class="st">&quot;RemEU&quot;</span>,<span class="st">&quot;RemUSA&quot;</span>),</span>
<span id="cb1-4"><a href="#cb1-4" tabindex="-1"></a>                               <span class="at">mean =</span> <span class="fu">c</span>(<span class="fl">37162.0</span>, <span class="fl">37705.0</span>, <span class="fl">37702.8</span>), </span>
<span id="cb1-5"><a href="#cb1-5" tabindex="-1"></a>                               <span class="at">sd =</span> <span class="fu">c</span>(<span class="fl">11113.62172</span>, <span class="fl">12332.41615</span>,<span class="fl">12113.72</span>))</span></code></pre></div>
</div>
<div id="sample-size-calculation-for-aucinf-equivalence-to-eu-remicade" class="section level1">
<h1>Sample Size Calculation for AUCinf: Equivalence to EU Remicade</h1>
<p>This example demonstrates how to calculate the required sample size
when testing the equivalence of SB2 to a reference drug, Remicade, as
administered in the EU. The goal is to determine the minimum number of
participants needed to ensure adequate power for the equivalence
test.</p>
<div id="hypotheses" class="section level2">
<h2>Hypotheses</h2>
<p>Null Hypothesis (No Equivalence): <span class="math display">\[H_0:
\frac{\mu_{SB2}}{\mu_{RemEU}} \le E_L ~~ or~~
\frac{\mu_{SB2}}{\mu_{RemEU}} \ge E_U\]</span></p>
<p>Alternative Hypothesis (Equivalence):</p>
<p><span class="math display">\[H_1:
E_L&lt;\frac{\mu_{SB2}}{\mu_{RemEU}} &lt; E_U\]</span></p>
<p>Here, <span class="math inline">\(E_L\)</span> and <span class="math inline">\(E_U\)</span> represent the lower and upper
equivalence margins, respectively.</p>
</div>
<div id="preparing-the-function-arguments" class="section level2">
<h2>Preparing the function arguments</h2>
<p>To proceed with the sample size calculation, we first need to
organize the mean and standard deviation values of each arm (SB2, EU
Remicade, USA Remicade) as list objects.</p>
<p>Since this example focuses on a single endpoint, the mean list
(<code>mu_list</code>) contains three scalar elements corresponding to
each arm, and the standard deviation list (<code>sigma_list</code>)
contains three 1x1 matrix elements.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a>mu_list <span class="ot">&lt;-</span> <span class="fu">as.list</span>(data<span class="sc">$</span>mean)  <span class="co"># Organize mean values into a list</span></span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>sigma_list <span class="ot">&lt;-</span> <span class="fu">as.list</span>(data<span class="sc">$</span>sd)  <span class="co"># Organize standard deviation values into a list</span></span></code></pre></div>
<p>Next, we define the comparison parameters, including the lower
(<code>lequi.tol</code>) and upper (<code>uequi.tol</code>) equivalence
boundaries, as well as the list of comparators. Since we are only
comparing two arms (SB2 and EU Remicade), the list of comparators
contains a single element specifying these two arms:</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a>list_comparator <span class="ot">&lt;-</span> <span class="fu">list</span>(<span class="st">&quot;Comparison&quot;</span> <span class="ot">=</span> <span class="fu">c</span>(<span class="st">&quot;SB2&quot;</span>,<span class="st">&quot;RemEU&quot;</span>))</span>
<span id="cb3-2"><a href="#cb3-2" tabindex="-1"></a>list_lequi.tol <span class="ot">&lt;-</span> <span class="fu">list</span>(<span class="st">&quot;Comparison&quot;</span> <span class="ot">=</span> <span class="fl">0.8</span>)</span>
<span id="cb3-3"><a href="#cb3-3" tabindex="-1"></a>list_uequi.tol <span class="ot">&lt;-</span> <span class="fu">list</span>(<span class="st">&quot;Comparison&quot;</span> <span class="ot">=</span> <span class="dv">1</span><span class="sc">/</span><span class="fl">0.8</span>)</span></code></pre></div>
</div>
<div id="computing-sample-size" class="section level2">
<h2>Computing Sample Size</h2>
<p>Finally, we use the <a href="../reference/sampleSize.html">sampleSize()</a> function to
calculate the required sample size based on stochastic simulations of
the trial. The function accepts several parameters, such as the desired
power, confidence level, and design specifications. By default, it
assumes:</p>
<ul>
<li>A parallel design,</li>
<li>A test based on the ratio of means (ROM),</li>
<li>Equal variances across arms,</li>
<li>A lognormal distribution for the endpoint.</li>
</ul>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" tabindex="-1"></a>AUCinf_1comp <span class="ot">&lt;-</span> <span class="fu">sampleSize</span>(</span>
<span id="cb4-2"><a href="#cb4-2" tabindex="-1"></a>  <span class="at">power =</span> <span class="fl">0.9</span>,                  <span class="co"># Target power</span></span>
<span id="cb4-3"><a href="#cb4-3" tabindex="-1"></a>  <span class="at">alpha =</span> <span class="fl">0.05</span>,                 <span class="co"># Confidence level</span></span>
<span id="cb4-4"><a href="#cb4-4" tabindex="-1"></a>  <span class="at">arm_names =</span> data<span class="sc">$</span>arm,         <span class="co"># Names of trial arms</span></span>
<span id="cb4-5"><a href="#cb4-5" tabindex="-1"></a>  <span class="at">list_comparator =</span> list_comparator,  <span class="co"># Comparator configuration</span></span>
<span id="cb4-6"><a href="#cb4-6" tabindex="-1"></a>  <span class="at">mu_list =</span> mu_list,            <span class="co"># Mean values</span></span>
<span id="cb4-7"><a href="#cb4-7" tabindex="-1"></a>  <span class="at">sigma_list =</span> sigma_list,      <span class="co"># Standard deviation values</span></span>
<span id="cb4-8"><a href="#cb4-8" tabindex="-1"></a>  <span class="at">list_lequi.tol =</span> list_lequi.tol,   <span class="co"># Lower equivalence boundary</span></span>
<span id="cb4-9"><a href="#cb4-9" tabindex="-1"></a>  <span class="at">list_uequi.tol =</span> list_uequi.tol,   <span class="co"># Upper equivalence boundary</span></span>
<span id="cb4-10"><a href="#cb4-10" tabindex="-1"></a>  <span class="at">nsim =</span> <span class="dv">1000</span>                   <span class="co"># Number of stochastic simulations</span></span>
<span id="cb4-11"><a href="#cb4-11" tabindex="-1"></a>)</span>
<span id="cb4-12"><a href="#cb4-12" tabindex="-1"></a></span>
<span id="cb4-13"><a href="#cb4-13" tabindex="-1"></a>AUCinf_1comp</span>
<span id="cb4-14"><a href="#cb4-14" tabindex="-1"></a><span class="co">#&gt; Sample Size Calculation Results</span></span>
<span id="cb4-15"><a href="#cb4-15" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb4-16"><a href="#cb4-16" tabindex="-1"></a><span class="co">#&gt; Study Design: parallel trial targeting 90% power with a 5% type-I error.</span></span>
<span id="cb4-17"><a href="#cb4-17" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb4-18"><a href="#cb4-18" tabindex="-1"></a><span class="co">#&gt; Comparisons:</span></span>
<span id="cb4-19"><a href="#cb4-19" tabindex="-1"></a><span class="co">#&gt;    SB2 vs. RemEU </span></span>
<span id="cb4-20"><a href="#cb4-20" tabindex="-1"></a><span class="co">#&gt;     - Endpoints Tested: y1 </span></span>
<span id="cb4-21"><a href="#cb4-21" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb4-22"><a href="#cb4-22" tabindex="-1"></a><span class="co">#&gt;                  Parameter     Value</span></span>
<span id="cb4-23"><a href="#cb4-23" tabindex="-1"></a><span class="co">#&gt;          Total Sample Size        84</span></span>
<span id="cb4-24"><a href="#cb4-24" tabindex="-1"></a><span class="co">#&gt;             Achieved Power      90.3</span></span>
<span id="cb4-25"><a href="#cb4-25" tabindex="-1"></a><span class="co">#&gt;  Power Confidence Interval 88.3 - 92</span></span>
<span id="cb4-26"><a href="#cb4-26" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span></code></pre></div>
<p>The required sample size for this scenario is 84, or 42 for each
arm.</p>
</div>
</div>
<div id="sample-size-calculation-for-aucinf-equivalence-to-us-remicade-and-eu-remicade" class="section level1">
<h1>Sample Size Calculation for AUCinf: Equivalence to US Remicade and
EU Remicade</h1>
<p>In this section, we calculate the sample size required to demonstrate
equivalence with both the European reference product (RemEU) and the US
reference product (RemUS). This scenario involves a more complex
comparison, as we must simultaneously establish equivalence with two
distinct reference arms.</p>
<div id="hypotheses-1" class="section level2">
<h2>Hypotheses</h2>
<p>Null Hypothesis (No Equivalence):</p>
<p><span class="math display">\[H_0: \frac{\mu_{SB2}}{\mu_{RemEU}} \le
E_L ~~ or~~ \frac{\mu_{SB2}}{\mu_{RemEU}} \ge E_U~~ or~~
\frac{\mu_{SB2}}{\mu_{RemUSA}} \le E_L ~~ or~~
\frac{\mu_{SB2}}{\mu_{RemUSA}} \ge E_U\]</span></p>
<p>Alternative Hypothesis (Equivalence):</p>
<p><span class="math display">\[H_1:
E_L&lt;\frac{\mu_{SB2}}{\mu_{RemEU}} &lt; E_U~~
and~~E_L&lt;\frac{\mu_{SB2}}{\mu_{RemUSA}} &lt; E_U\]</span> <strong>Key
Considerations</strong></p>
<ul>
<li>The function <a href="../reference/sampleSize.html">sampleSize()</a>
adjusts the alpha level for multiple comparisons within a single
comparator (e.g., comparisons involving only RemEU or RemUSA).</li>
<li>The function does not yet account for alpha adjustments between
comparators when simultaneously comparing SB2 with both reference
products (RemEU and RemUSA). Thus, the null hypothesis is rejected if
any ROM falls outside the equivalence boundaries. Future package updates
will address this limitation and include proper alpha adjustments for
comparisons between comparators.</li>
</ul>
</div>
<div id="implementation-details" class="section level2">
<h2>Implementation Details</h2>
<p>Implementation of this scenario is similar to the initial example, in
which the <code>list_comparator</code> is modified to include multiple
comparators. The list contains two elements specifying the simultaneous
comparison between SB2 vs. RemEU and SB2 vs. RemUSA. This approach
ensures that the equivalence assessment accounts for both reference
products.</p>
<p>Additionally, we must specify equivalence boundaries for each
comparison individually. These boundaries define the acceptable range
for equivalence and are provided separately for each comparator.</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" tabindex="-1"></a>list_comparator <span class="ot">&lt;-</span> <span class="fu">list</span>(<span class="st">&quot;EMA&quot;</span> <span class="ot">=</span> <span class="fu">c</span>(<span class="st">&quot;SB2&quot;</span>, <span class="st">&quot;RemEU&quot;</span>),</span>
<span id="cb5-2"><a href="#cb5-2" tabindex="-1"></a>                        <span class="st">&quot;FDA&quot;</span> <span class="ot">=</span> <span class="fu">c</span>(<span class="st">&quot;SB2&quot;</span>, <span class="st">&quot;RemUSA&quot;</span>))</span>
<span id="cb5-3"><a href="#cb5-3" tabindex="-1"></a>list_lequi.tol <span class="ot">&lt;-</span> <span class="fu">list</span>(<span class="st">&quot;EMA&quot;</span> <span class="ot">=</span> <span class="fl">0.8</span>, <span class="st">&quot;FDA&quot;</span> <span class="ot">=</span> <span class="fl">0.8</span>)     <span class="co"># Lower equivalence boundary</span></span>
<span id="cb5-4"><a href="#cb5-4" tabindex="-1"></a>list_uequi.tol <span class="ot">&lt;-</span> <span class="fu">list</span>(<span class="st">&quot;EMA&quot;</span> <span class="ot">=</span> <span class="dv">1</span><span class="sc">/</span><span class="fl">0.8</span>, <span class="st">&quot;FDA&quot;</span> <span class="ot">=</span> <span class="dv">1</span><span class="sc">/</span><span class="fl">0.8</span>) <span class="co"># Upper equivalence boundary</span></span></code></pre></div>
</div>
<div id="computing-sample-size-1" class="section level2">
<h2>Computing Sample Size</h2>
<p>We then pass these values into the <a href="../reference/sampleSize.html">sampleSize()</a> function to
calculate the required sample size for multiple comparisons.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" tabindex="-1"></a>(AUCinf_2comp <span class="ot">&lt;-</span> <span class="fu">sampleSize</span>(</span>
<span id="cb6-2"><a href="#cb6-2" tabindex="-1"></a>  <span class="at">power =</span> <span class="fl">0.9</span>,                  <span class="co"># Target power</span></span>
<span id="cb6-3"><a href="#cb6-3" tabindex="-1"></a>  <span class="at">alpha =</span> <span class="fl">0.05</span>,                 <span class="co"># Confidence level</span></span>
<span id="cb6-4"><a href="#cb6-4" tabindex="-1"></a>  <span class="at">arm_names =</span> data<span class="sc">$</span>arm,         <span class="co"># Names of trial arms</span></span>
<span id="cb6-5"><a href="#cb6-5" tabindex="-1"></a>  <span class="at">list_comparator =</span> list_comparator,  <span class="co"># Comparator configuration</span></span>
<span id="cb6-6"><a href="#cb6-6" tabindex="-1"></a>  <span class="at">mu_list =</span> mu_list,            <span class="co"># Mean values</span></span>
<span id="cb6-7"><a href="#cb6-7" tabindex="-1"></a>  <span class="at">sigma_list =</span> sigma_list,      <span class="co"># Standard deviation values</span></span>
<span id="cb6-8"><a href="#cb6-8" tabindex="-1"></a>  <span class="at">list_lequi.tol =</span> list_lequi.tol,   <span class="co"># Lower equivalence boundary</span></span>
<span id="cb6-9"><a href="#cb6-9" tabindex="-1"></a>  <span class="at">list_uequi.tol =</span> list_uequi.tol,   <span class="co"># Upper equivalence boundary</span></span>
<span id="cb6-10"><a href="#cb6-10" tabindex="-1"></a>  <span class="at">nsim =</span> <span class="dv">1000</span>                   <span class="co"># Number of stochastic simulations</span></span>
<span id="cb6-11"><a href="#cb6-11" tabindex="-1"></a>))</span>
<span id="cb6-12"><a href="#cb6-12" tabindex="-1"></a><span class="co">#&gt; Sample Size Calculation Results</span></span>
<span id="cb6-13"><a href="#cb6-13" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb6-14"><a href="#cb6-14" tabindex="-1"></a><span class="co">#&gt; Study Design: parallel trial targeting 90% power with a 5% type-I error.</span></span>
<span id="cb6-15"><a href="#cb6-15" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-16"><a href="#cb6-16" tabindex="-1"></a><span class="co">#&gt; Comparisons:</span></span>
<span id="cb6-17"><a href="#cb6-17" tabindex="-1"></a><span class="co">#&gt;    SB2 vs. RemEU </span></span>
<span id="cb6-18"><a href="#cb6-18" tabindex="-1"></a><span class="co">#&gt;     - Endpoints Tested: y1 </span></span>
<span id="cb6-19"><a href="#cb6-19" tabindex="-1"></a><span class="co">#&gt;    SB2 vs. RemUSA </span></span>
<span id="cb6-20"><a href="#cb6-20" tabindex="-1"></a><span class="co">#&gt;     - Endpoints Tested: y1 </span></span>
<span id="cb6-21"><a href="#cb6-21" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span>
<span id="cb6-22"><a href="#cb6-22" tabindex="-1"></a><span class="co">#&gt;                  Parameter     Value</span></span>
<span id="cb6-23"><a href="#cb6-23" tabindex="-1"></a><span class="co">#&gt;          Total Sample Size       150</span></span>
<span id="cb6-24"><a href="#cb6-24" tabindex="-1"></a><span class="co">#&gt;             Achieved Power        91</span></span>
<span id="cb6-25"><a href="#cb6-25" tabindex="-1"></a><span class="co">#&gt;  Power Confidence Interval 89 - 92.7</span></span>
<span id="cb6-26"><a href="#cb6-26" tabindex="-1"></a><span class="co">#&gt; -------------------------------------------------------------</span></span></code></pre></div>
</div>
<div id="results-and-interpretation" class="section level2">
<h2>Results and Interpretation</h2>
<p>The required total sample size for this scenario is 150. Notably, an
additional 8 patients per arm are required to achieve equivalence with
both reference products (RemEU and RemUSA), compared to the scenario
where equivalence is required with only one reference arm (42).</p>
<p>This example demonstrates the added complexity and sample size
requirements when multiple comparators are involved in an equivalence
trial.</p>
<p>The SimTOST package includes the <a href="../reference/plot.simss.html">plot()</a> function, which is
designed to permit visualization of the relationship between sample size
(x-axis) and achieved power (y-axis) for all combinations of endpoints
and comparators. In this example, we use the <a href="../reference/plot.simss.html">plot()</a> function to generate a
plot for the <code>AUCinf_2comp</code> object.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" tabindex="-1"></a><span class="fu">plot</span>(AUCinf_2comp)</span></code></pre></div>
<p><img role="img" src="data:image/png;base64,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" width="95%" /></p>
</div>
</div>
<div id="references" class="section level1 unnumbered">
<h1 class="unnumbered">References</h1>
<div id="refs" class="references csl-bib-body hanging-indent" entry-spacing="0">
<div id="ref-sozu_sample_2015" class="csl-entry">
Sozu, Takashi, Tomoyuki Sugimoto, Toshimitsu Hamasaki, and Scott R.
Evans. 2015. <em>Sample <span>Size Determination</span> in
<span>Clinical Trials</span> with <span>Multiple Endpoints</span></em>.
<span>SpringerBriefs</span> in <span>Statistics</span>. Cham: Springer
International Publishing. <a href="https://doi.org/10.1007/978-3-319-22005-5">https://doi.org/10.1007/978-3-319-22005-5</a>.
</div>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
